Drug Profile
BR 14
Alternative Names: BR-14Latest Information Update: 22 Aug 2007
Price :
$50
*
At a glance
- Originator Bracco
- Developer Bracco; University of Virginia
- Class Contrast media; Fluorocarbons; Phospholipids
- Mechanism of Action Ultrasonography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary disorders; Liver disorders
Most Recent Events
- 22 Aug 2007 Discontinued - Phase-II for Liver disorders(diagnosis) in Germany (unspecified route)
- 22 Aug 2007 Discontinued - Preclinical for Coronary disorders (diagnosis) in USA (unspecified route)
- 16 Oct 2003 No development reported - Phase-II for Liver disorders (diagnosis) in Germany (unspecified route)